Skip to main content

Table 2 Prevalence of seropositivity to three malarial antigens in children who received seasonal malaria chemoprevention (SMC) for 2 years or for 4 years

From: Effect of 4 years of seasonal malaria chemoprevention on the acquisition of antibodies to Plasmodium falciparum antigens in Ouelessebougou, Mali

  n % 95% CI Unadjusted Adjusteda
OR 95% CI p OR 95% CI p
AMA1
 SMC 2 years 215 88.8 84.5–92.8 Ref Ref
 SMC 4 years 205 95.3 92.5–98.2 2.57 1.22–5.45 0.014 3.16 1.44–6.95 0.004
MSP-142
 SMC 2 years 208 86.0 81.5–90.4 Ref Ref
 SMC 4 years 183 85.1 80.3–90.0 0.93 0.55–1.58 0.8 1.06 0.62–1.80 0.8
CSP
 SMC 2 years 196 81.9 76.0–86.0 Ref Ref
 SMC 4 years 197 91.2 87.0–95.4 2.57 1.43–4.59 0.001 3.14 1.70–5.76  < 0.001
  1. SMC 2 years = received SMC for 2 years; SMC 4 years = received SMC for 4 years
  2. aadjusted for age, gender and malaria infection